SARS-CoV-2 infections in patients, health care workers and hospital outbreaks during the first 3 waves of the pandemic: a retrospective analysis in a secondary care hospital network in Germany.
Anke HildebrandtKirsten DolegaLutz UflackerHenrik RudolfSören G GatermannPublished in: BMC infectious diseases (2024)
This research was conducted in accordance with the Declaration of Helsinki and national standards. The study protocol was approved by the relevant ethics committee of the Chamber of Physicians Westphalia-Lippe and University of Münster (no. 2021-475-f-S). The study was registered on 25th August 2021 at the German Clinical Trials Register (DRKS00025865).
Keyphrases
- sars cov
- clinical trial
- healthcare
- end stage renal disease
- study protocol
- quality improvement
- randomized controlled trial
- newly diagnosed
- ejection fraction
- primary care
- chronic kidney disease
- coronavirus disease
- public health
- prognostic factors
- peritoneal dialysis
- acute care
- palliative care
- open label
- emergency department
- adverse drug
- pain management
- double blind
- drug administration
- artificial intelligence
- global health
- network analysis